Oorsprong van het eerstegraads netwerk van Suzy Beckham
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Altiris Therapeutics, Inc.
Altiris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Suzy Beckham via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Incyte Pharmaceuticals, Inc.
Incyte Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company was founded in April, 1991 is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ZP Opco, Inc.
ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member | |
Georgia Venture Partners LLC
Georgia Venture Partners LLC Investment ManagersFinance Georgia Venture Partners LLC(Georgia Venture Partners) is an Independent Venture Capital firm founded in 2004 by John P. Richard and Thomas H. Callaway. The firm is headquartered in Atlanta. | Investment Managers | Founder | |
Abeome Corp.
Abeome Corp. BiotechnologyHealth Technology Abeome Corp. operates as a biotechnology company. It develops therapeutic and diagnostic monoclonal antibodies (mAbs). The firm’s DiSH (Direct Selection of Hybridomas) technology offers a process for selecting and cloning desired hybridomas that produce antibodies with optimal binding characteristics. The company was founded by Richard B. Meagher in 2000 and is headquartered in Athens, GA. | Biotechnology | Director/Board Member | |
SEQUUS Pharmaceuticals, Inc.
SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
VIVUS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
J.E.M. CAPITAL INC | Financial Conglomerates | Director/Board Member | |
Phase4 Partners Ltd.
Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
QUE Oncology, Inc.
QUE Oncology, Inc. Pharmaceuticals: MajorHealth Technology QUE Oncology, Inc. engages in preventing and treating life-threatening cancers such as prostate cancer, breast cancer, melanoma, and cancer pain; and related conditions. The company is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Director/Board Member | |
MEREO BIOPHARMA GROUP PLC | Biotechnology | Founder | |
VAXART, INC. | Biotechnology | Director/Board Member | |
Stanford University | College/University | Undergraduate Degree | |
Cogenics Icoria, Inc.
Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The University of North Carolina at Charlotte | College/University | Masters Business Admin | |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member | |
University of Michigan | College/University | Corporate Officer/Principal | |
University of Wisconsin | College/University | Doctorate Degree | |
Parke, Davis & Co. LLC | Corporate Officer/Principal | ||
BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
VIRALYTICS LTD. | Biotechnology | Director/Board Member | |
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Vivace Therapeutics, Inc.
Vivace Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vivace Therapeutics, Inc. discovers and develops novel cancer drug. The company was founded by Shuang Qiao in 2014 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Biotechnology | Director/Board Member | |
University of San Diego | College/University | Undergraduate Degree | |
Parke-Davis & Co. Ltd.
Parke-Davis & Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Parke-Davis & Co. Ltd. is a British pharmaceutical company. The company is based in St. Helier, UK. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Orphagen Pharmaceuticals
Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Oxyrane UK Ltd.
Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Infectious Disease Research Institute
Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Director/Board Member | |
CG ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
UNIQURE N.V. | Biotechnology | Director/Board Member | |
Virtuoso Therapeutics, Inc.
Virtuoso Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Virtuoso Therapeutics, Inc. is an oncology-focused small molecule drug discovery and development company. The company is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
FULGENT GENETICS, INC. | Medical/Nursing Services | Director/Board Member | |
ImmVirX Pty Ltd.
ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019. | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 42 |
Verenigd Koninkrijk | 6 |
Australië | 3 |
Hongkong | 2 |
Nederland | 2 |
Sectoraal
Health Technology | 32 |
Commercial Services | 7 |
Consumer Services | 7 |
Finance | 4 |
Health Services | 3 |
Operationeel
Director/Board Member | 32 |
Corporate Officer/Principal | 10 |
Chief Tech/Sci/R&D Officer | 7 |
Independent Dir/Board Member | 7 |
Founder | 4 |
Sterkste connecties
Insiders | |
---|---|
Leonard Post | 25 |
John P. Richard | 24 |
Douglas H. Gooding | 7 |
- Beurs
- Insiders
- Suzy Beckham
- Bedrijfsconnecties